Evaluation of the 2-year AVF Utilization Rate | NCT07548814

Studies
Evaluation of the 2-year AVF Utilization Rate

NCT07548814

Sponsor

University Paul Sabatier of Toulouse

Status

Active, not recruiting

Last Update Posted

Apr 23, 2026Actual

Enrollment

1,000Estimated

Phase

Not provided

Conditions

Dialysis Access Dysfunction
Fistulae

Interventions

AVF creation as indicated by the nephrologist

Countries

France

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Jan 2026

Overall Recruitment Status or Expanded Access Status

Active, not recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jan 1, 2018Actual

Primary Completion Date

Jan 1, 2026Actual

Completion Date

Dec 1, 2026Estimated

First Submitted Date

Apr 14, 2026

First Submission Date that Met QC Criteria

Apr 21, 2026

First Posted Date

Apr 23, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Apr 21, 2026

Last Update Posted Date

Apr 23, 2026Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Aurélien Hostalrich, MD-PhD, associated Head of vascular surgery departement, University Paul Sabatier of ToulousePrincipal Investigator

Lead Sponsor

University Paul Sabatier of ToulouseOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Arteriovenous fistulas (AVFs) are the standard for dialysis sessions. However, this usually requires surgery before dialysis can begin. Given this pre-operative approach, the investigators evaluate the two-year utilization rate of AVFs and seek to understand why they are still not used in some cases.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

1,000Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
AVF creation non dialysed patient			Procedure: AVF creation as indicated by the nephrologist

Interventions

Name	Type	Description	Arm Group Labels	Other Names
AVF creation as indicated by the nephrologist	Procedure	AVF are creation in the OR when asked by the nephrologist team	AVF creation non dialysed patient

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
AVF utilisation	AVF puncture	through study completion, an average of 2 years

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

First AVF creation

Exclusion Criteria:

Minor patient
AVF already

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

Patients for whom the neprhologist indicated an AVF creation

Sampling Method

Probability Sample

Facility	Status	City	State	ZIP	Country	Contacts
Benane Dylan		Toulouse		31400	France

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided